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Introduction: Recent studies have shown that radical gastrectomy with extended lymphadenectomy is
feasible in gastric cancer patients with liver cirrhosis, but in those studies the main proportion was Child-
Pugh class A patients. It is still difﬁcult to choose reasonable surgical strategies for gastric cancer patients
with cirrhosis, especially for Child-Pugh class B patients.
Methods: We reviewed the medical records of patients with liver cirrhosis who had undergone radical
gastrectomy between January 2001 and December 2012. The clinical characteristics, postoperative
complications, mortality and long-term outcomes in the 58 patients were investigated.
Results: Severe complications and postoperative mortality occurred more frequently in class B patients
than in class A patients (P < 0.05). In patients with class A and B, the complications and mortality rate
was 37.5% and 4.2% in D1 lymph node dissection group and 71.9% and 25% in D2 lymph node dissection
group, respectively. KaplaneMeier survival analysis showed longer survival for class A patients than for
class B patients (P < 0.05). For class B patients with advanced gastric cancer, D2 lymph node dissection
could not provide a longer survival than D1 lymph node dissection (P ¼ 0.282).
Conclusion: Radical operation with D1 or D2 lymph node dissection can be tolerated in class A gastric
cancer patients. D1 lymph node dissection is recommended in class B patients, and radical gastrectomy is
very dangerous, even fatal for class C patients.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.ery, Huashan North Hospital,
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Despite a major decline in incidence and mortality, gastric
cancer (GC) is still one of the most commonly diagnosed tumors
worldwide [1]. In 2008, about 0.98 million new GC cases were
diagnosed and 0.74million GC deaths occurred in theworld [2]. The
geographical distribution of GC is very different, and the incidence
is particularly high in East Asia, Eastern Europe, Central and South
America [3,4]. In 2008, incidence and mortality of GC ranked sec-
ond in China, after lung cancer [5]..
Table 1
Patients' characteristics.
Child-Pugh classiﬁcation Total (n ¼ 58)
Class A
(n ¼ 25)
Class B
(n ¼ 31)
Class C
(n ¼ 2)
Age (years)
Median 64 63 63
Range 39e75 42e72 48,65 39e75
Sex
Male 18 (72%) 24 (77.4%) 2 (100%) 44 (75.9%)
Female 7 (28%) 7 (22.6%) 0 14 (24.1%)
Cause of cirrhosis
Hepatitis B virus 14 (56%) 24 (77.4%) 2 (100%) 40 (70%)
Hepatitis C virus 1 (4%) 6 (19.4%) 0 7 (12.1%)
Schistosomiasis 8 (32%) 1 (3.2%) 0 9 (15.5%)
Alcohol 1 (4%) 0 0 1 (1.7%)
Cryptogenic 1 (4%) 0 0 1 (1.7%)
Extent of gastric resection
Subtotal gastrectomy 20 (80%) 22 (71%) 2 (100%) 44 (75.9%)
Total gastrectomy 5 (20%) 9 (29%) 0 14 (24.1%)
Extent of lymphadenectomy
D1 lymphadenectomy 10 (40%) 14 (45.2%) 2 (100%) 26 (44.8%)
D2 lymphadenectomy 15 (60%) 17 (54.8%) 0 32 (55.2%)
Postoperative albumin 20 (80%) 29 (93.5%) 2 (100%) 49 (84.5%)
Postoperative diuretics 8 (32%) 22 (71%) 2 (100%) 32 (55.2%)
Tumor stage
IA 2 (8%) 4 (13%) 0 6 (10.4%)
IB 6 (24%) 5 (16.1%) 0 11 (19%)
IIA 1 (4%) 2 (6.4%) 0 3 (5.2%)
IIB 4 (16%) 6 (19.4%) 0 10 (17.2%)
IIIA 6 (24%) 8 (25.8%) 0 14 (24.1%)
IIIB 4 (16%) 4 (12.9%) 2 (100%) 10 (17.2%)
IIIC 2 (8%) 1 (3.2%) 0 3 (5.2%)
IV 0 1 (3.2%) 0 1 (1.7%)
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schistosomiasis, which are once endemic in China [6,7]. Therefore,
LC is frequently encountered among candidates for GC surgery. It is
well known that surgery in patients with LC is dangerous and the
incidence of postoperative complications and postoperative mor-
tality is high [8e10]. Several studies from Japan and Korea have
discussed the risk of GC surgery in LC patients [11,12]. However, it is
still difﬁcult and controversial to develop the therapeutic strategies
for GC patients with LC, especially to keep the balance between the
extent of surgery and the incidence of postoperative complications
and mortality. Therefore, in this retrospective study we reviewed
the causes of cirrhosis, postoperative complications, mortality in
GC patients with LC, with the aim to choose the best surgical
strategy for these patients.
2. Methods
2.1. Patients
We reviewed the medical records of 3417 patients who were
diagnosed as gastric adenocarcinoma by pathological biopsy at
Huashan Hospital afﬁliated to Fudan University between January
2001 and December 2012. Of those patients, 74 patients had LC.
Four patients who had palliative surgery and 12 patients who had
no surgery due to severe liver dysfunction, late staging and poor
physical conditions were excluded. Finally, the clinical data of 58
patients were analyzed in this study.
2.2. Preoperative evaluation and surgical procedure
LC was conﬁrmed primarily by existing pathological results or
preoperative biopsy. In patients who had no liver biopsy, LC was
diagnosed based on the history of liver disease, preoperative blood
biochemical examination, CT scan, ultrasonography imaging and
ﬁndings during the operation. For 9 patients with LC due to
schistosomiasis japonica, postoperative pathological reports
showed that Schistosome eggs were deposited in gastrointestinal
submucosal.
Preoperative assessment included complete blood count, blood
biochemical tests, blood coagulation function and serologic tests
for hepatitis virus antigen and antibody (including hepatitis B virus
surface antigen (HBsAg), hepatitis B virus surface antibody (HBsAb),
hepatitis B virus e antigen (HBeAg), hepatitis B virus e antibody
(HBeAb), hepatitis B virus core antibody (HBcAb) and hepatitis C
virus antibody (HCVAb)). The Child-Pugh classiﬁcation was used to
evaluate the severity of liver damage. In some patients whose
original score was from the Child classiﬁcation, the Child-Pugh
classiﬁcation was applied to re-evaluate.
Curative surgery was deﬁned as subtotal or total gastrectomy
and D1 or D2 lymphadenectomy according to Japanese gastric
cancer treatment guidelines 2010 [13]. D1þ Nos. 8a and/or 9 LN
dissection was classiﬁed as D1 lymphadenectomy in this study.
Early gastric cancer comprised of T1 tumors irrespective of lymph
node metastasis, and TNM staging was determined as described
previously [14]. Nasogastric or nasojejunal decompression and 1 or
2 closed abdominal drains were used routinely. The nasogastric or
nasojejunal tube was usually left for a few days until the return of
bowel function. Drainage tube was removed after eating and daily
drainage volume was less than 150 ml. Massive ascites was deﬁned
as postoperative drainage of more than 500 ml per day.
2.3. Collection of clinical data
The following clinical data were extracted and analyzed: de-
mographic ﬁndings, cause of cirrhosis, Child-Pugh class, extent ofgastric resection, extent of lymphadenectomy, postoperative albu-
min infusion, postoperative diuretics, tumor stage, postoperative
complications, postoperative mortality, daily drainage volume
through the JacksonePratt drain in two weeks after surgery and
long-term outcomes.
2.4. Statistical analysis
Statistical analysis was performed using the SPSS 18.0. Collected
data were expressed as medians, frequencies, percentages and
mean ± SD. The chi-squared test or Fisher's exact test, and Student's
t test were used for the comparison. Overall survival (OS) was
calculated from the time of operation to the date of death or the
most recent follow-up. Survival curves were estimated using the
KaplaneMeier method and compared by the log-rank test. The chi-
squared test or Fisher's exact test and Student's t test were two-
sided. Statistical signiﬁcance was set at p < 0.05.
3. Results
3.1. Clinical characteristics
A total of 58 patients with liver cirrhosis who underwent
curative surgery for GC were enrolled in this study. Patients'
baseline characteristics were shown in Table 1. There were 44 male
(75.9%) and 14 female (24.1%) patients with a median age of 63
years (range, 39e75 years). Twenty-ﬁve (43.1%), thirty-one (53.5%)
and two (3.4%) patients were classiﬁed into class A, B and C,
respectively. In 35 patients, LC was conﬁrmed by pathological re-
sults. The causes of cirrhosis were HBV (70%), schistosomiasis
(15.5%), HCV (12.1%), alcohol (1.7%) and cryptogenic (1.7%). Schis-
tosomial cirrhosis occurred more frequently in class A than in class
B and C (P ¼ 0.004).
Fig. 1. In patients with class A and B (n ¼ 56), postoperative drainage trends in group
with bleeding, leakage, pneumonia or hepatic failure (n ¼ 14) and in group without
bleeding, leakage, pneumonia and hepatic failure (n ¼ 42). *p < 0.05.
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(24.1%) patients had total gastrectomy. D1 and D2 lymphadenec-
tomy was performed in 26 (44.8%) and 32 (55.2%) patients,
respectively. Seventeen patients (29.3%) had early gastric cancer
(EGC) and 41 (70.7%) patients had advanced gastric cancer (AGC).
For patients in either class A, class B or class C, albumin has been
widely used after surgery, but postoperative diuretics were used
more frequently in patients with class B than in patients with class
A (P ¼ 0.007).
3.2. Severe complications and mortality
Postoperative severe complications, including massive ascites,
postoperative bleeding, anastomosis leakage, pneumonia and
hepatic failure, developed in 34 (58.6%) of 58 patients (Table 2).
Severe complications occurred more frequently in patients with
class B than in patients with class A (P ¼ 0.03). In patients with
Child-Pugh class A and B, 9 (37.5%) patients who underwent D1 LN
dissection and 23 (71.9%) patients who underwent D2 LN dissec-
tion experienced severe complications (P ¼ 0.015). Postoperative
hepatic failure and mortality occurred in both of the patients with
class C.
Postoperative massive ascites was the most common compli-
cation, and occurredmore frequently in patients (67.7%) with class
B than in patients (36%) with class A (P ¼ 0.03). In patients with
Child-Pugh class A and B, signiﬁcant difference was found: 7 pa-
tients (29.2%) in the D1 LN dissection group and 23 patients
(71.9%) in the D2 dissection group experienced massive ascites
(P ¼ 0.003).
Furthermore, in patients with class A and B, the daily drainage
volume in no bleeding, leakage, pneumonia and hepatic failure
group (n ¼ 42) reached peak value on the ﬁfth day after surgery,
while in bleeding, leakage, pneumonia or hepatic failure group
(n¼ 14), drainage volume did not decrease in the secondweek after
surgery (Fig 1), and postoperative mortality developed in 9 of the
14 patients, including 7 class B patients who underwent D2 LN
dissection.
Postoperative mortality occurred in 11 patients (19%), among
who 7 patients died from hepatic failure, 2 patients died from
bleeding, 1 died from anastomosis leakage and 1 died from pneu-
monia. In patients with class A and B, the mortality rate was 4.2% in
D1 LN dissection group and 25% in D2 LN dissection group, with no
signiﬁcant difference (P¼ 0.063). However, postoperativemortality
occurred more frequently in patients with class B (25.8%) than in
those with class A (4%) (P ¼ 0.033).
3.3. Long-term outcomes
36 of the 58 patients died after surgery. The causes of death
were as follows: 13 patients died from recurrence of gastric cancer;
11 patients died from postoperative severe complications; 9 pa-
tients died from hepatoma and hepatitis; and 3 patients died fromTable 2
Postoperative severe complications and mortality.
Child-Pugh class A (n ¼ 25) Child-
D1 (n ¼ 10) D2 (n ¼ 15) D1 (n
Severe complication 2 8 7
Massive ascites 1 8 6
Postoperative bleeding 0 1 1
Anastomosis leakage 0 0 0
Pneumonia 1 2 2
Hepatic failure 0 1 1
Mortality 0 1 1other causes. With a median follow-up of 45 months (range,
0.6e132 months), 5-year overall survival rate (OS) was 41.1% for all
patients; 69.7% for patients with EGC; 29% for patients with AGC;
54% for patients with class A; 33.1% for patients with class B. The
KaplaneMeier survival curves revealed that there was longer sur-
vival for patients with class A than for patients with class B
(P ¼ 0.042, Fig 2A); and for patients with AGC in class B, D2 LN
dissection could not provide a longer survival than D1 LN dissection
(P ¼ 0.282, Fig 2B).4. Discussion
Liver cirrhosis is a chronic degenerative processes caused by a
variety of disease. It is well known that viral hepatitis B have been
particularly prevalent in southeastern China, and hepatitis B sur-
face antigen (HBsAg) carrier rate in thewhole populationwas 9.75%
[6]. However, in this study, we found that in 9 patients LC was
caused by schistosomiasis japonica. This may be due to endemic
schistosomiasis japonica in the Yangtze River Basin in the 1960s,
when there were about ten million schistosomiasis patients in
China [15,16].
It is a consensus that surgical risk increases in patients with
cirrhosis, and the severity of risk ia correlated with the degree of
hepatic decompensation [8]. In this retrospective study, the post-
operative severe complications, mortality, and long-term outcome
for patients who had curative surgery for gastric cancer combined
with LC were investigated. Severe complications and mortality
occurred more frequently for patients with Child-Pugh class B than
for those with Child-Pugh class A. Massive ascites was the most
common complications in patients with LC who underwent radicalPugh class B (n ¼ 31) Child-Pugh class C
D1 (n ¼ 2)
Total (n ¼ 58)
¼ 14) D2 (n ¼ 17)
15 2 34 (58.6%)
15 2 32 (55.2%)
1 0 3 (5.2%)
1 0 1 (1.7%)
3 1 9 (15.5%)
7 2 11 (19%)
7 2 11 (19%)
Fig. 2. Comparison of survival curves. A. KaplaneMeier survival curves revealed that there was longer survival for patients with class A than for patients with class B (P ¼ 0.042). B.
For patients with AGC in class B, D2 LN dissection could not provide a longer survival than D1 LN dissection (P ¼ 0.282).
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extent of lymphadenectomy were associated with the incidence of
ascites, and massive ascites developed more frequently in patients
with class B or underwent D2 LN dissection than in patients with
class A or underwent D1 LN dissection. According to the previous
report, the incidence of massive ascites was 20e30% [12]. However,
in this study, the incidence of massive ascites was 67.7%. Wespeculated that the difference is due to prophylactic drains after the
operation and a higher proportion of class B in this series. In
addition, in most of class A and B patients without bleeding,
leakage, pneumonia and hepatic failure, ascites could be controlled
within two weeks after surgery, despite higher usage rate of albu-
min and diuretics. In contrast, in class A and B patients with
bleeding, leakage, pneumonia or hepatic failure, ascites was
F. Guo et al. / International Journal of Surgery 12 (2014) 810e814814difﬁcult to control, and postoperative mortality occurred
frequently. Furthermore, most of these complications and the
mortality occurred in patients with class B and those who under-
went D2 LN dissection.
The mortality rate is 80e85% in patients with Child-Pugh class C
undergoing major abdominal surgery, and class C cirrhosis is
considered to be a contraindication for major abdominal surgery
[8,10,17]. In this study, postoperative hepatic failure and hospital
death occurred in both of the patients with class C, consistent with
the above conclusion.
For GC patients with class A and B, it is challenging to select the
appropriate treatment strategy and surgical approach. There were
no randomized controlled trials except a limited number of
retrospective studies. The results of these studies showed that D2
LN dissection is feasible in patients with LC. However, in those
studies, the proportion of class A patients was 80.7e87.2%, sug-
gesting that D2 LN dissection is feasible in class A patients. A high
proportion of patients with decompensated LC suffered from
portal hypertension, esophageal or gastric varices, hypo-
proteinemia and coagulopathy, which inevitably leads to more
blood loss, longer operative time, higher surgical difﬁculty and
higher surgical risk. The aim of surgery is to prolong life and
improve the quality of life. Because of the higher surgical risk, it is
not easy to control the balance between the extent of surgery and
the perioperative risk. For advanced gastric cancer, the debate
between D1 and D2 LN dissection has spanned several decades.
According to recent randomized controlled trials, D2 LN dissection
was the recommended surgical approach because it provided
better locoregional control and better cancer-speciﬁc survival
compared with D1 LN dissection, although D2 LN dissection was
associated with higher postoperative mortality, morbidity, and
reoperation rates [18]. In this study, in patients with class A,
operative mortality was zero in D1 LN dissection patients and 6.7%
in D2 LN dissection patients, similar to the results of Dutch trail:
4% in D1 patients and 10% in D2 patients [18]. 5-year survival rate
of class A patients was 54%, also similar to the results of Dutch trail
45e47% [18].
In 31 class B patients, 17 patients underwent D2 LN dissection
and 14 patients underwent D1 LN dissection. Most of severe com-
plications (except ascites) and mortality occurred in D2 LN
dissection patients. The operative mortality was 41.2% in D2 LN
dissection group, signiﬁcantly higher than 7.1% operative mortality
in D1 LN dissection group and 10% in Dutch trial. Additionally, for
patients with AGC in class B, because of higher perioperative
mortality and cirrhosis-related deaths D2 LN dissection gained no
long-term beneﬁt compared to D1 LN dissection. Based on the
above, D1 LN dissection is the reasonable surgical approach for
patients with class B.
Taken together, our results demonstrated that radical operation
with D1 or D2 LN dissection could be tolerated in patients with
class A. D1 LN dissection is recommended in patients with class B
and radical gastrectomy is very dangerous and even fatal for pa-
tients with class C.Ethical approval
This study was approved by Ethics Committee of Huashan
Hospital afﬁliated to Fudan University.Author contribution
FL and ZW designed the study; FG, SM, SY collected the data; YD
performed statistical analysis.
Funding
None.
Conﬂict of interest
None declared.
Acknowledgments
The authors thank Dr. Xiaobo Li, Department of Physiology and
Pathophysiology, Fudan University Shanghai Medical College,
Shanghai, and Shengmei Feng, Shanghai Roche Pharmaceuticals
Ltd, for their constructive comments.
References
[1] A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer
statistics, CA Cancer J. Clin. 61 (2011) 69e90.
[2] J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, Estimates of
worldwide burden of cancer in 2008: GLOBOCAN, Int. J. Cancer 2010 (127)
(2008) 2893e2917.
[3] A. Gallo, C. Cha, Updates on esophageal and gastric cancers, World J. Gastro-
enterol. 12 (2006) 3237e3242.
[4] D.M. Roder, The epidemiology of gastric cancer, Gastric Cancer 5 (Suppl.)
(2002) s5es11.
[5] W.Q. Chen, R.S. Zheng, S.W. Zhang, N. Li, P. Zhao, G.L. Li, et al., Report of
incidence and mortality in china cancer registries, Chin. J. Cancer Res. 2012
(24) (2008) 171e180.
[6] Y. Cui, J. Jia, Update on epidemiology of hepatitis B and C in China,
J. Gastroenterol. Hepatol. 28 (Suppl.) (2013) 7e10.
[7] L.D. Wang, J.G. Guo, X.H. Wu, H.G. Chen, T.P. Wang, S.P. Zhu, et al., China's
new strategy to block Schistosoma japonicum transmission: experiences
and impact beyond schistosomiasis, Trop. Med. Int. Health 14 (2009)
1475e1483.
[8] A. Mansour, W. Watson, V. Shayani, J. Pickleman, Abdominal operations in
patients with cirrhosis: still a major surgical challenge, Surgery 122 (1997)
730e735 (discussion 735e736).
[9] M. Tachibana, T. Kotoh, S. Kinugasa, D.K. Dhar, M. Shibakita, S. Ohno, et al.,
Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18
consecutive patients, Ann. Surg. Oncol. 7 (2000) 758e763.
[10] P. Gervaz, R. Pak-art, S. Nivatvongs, B.G. Wolff, D. Larson, S. Ringel, Colo-
rectal adenocarcinoma in cirrhotic patients, J. Am. Coll. Surg. 196 (2003)
874e879.
[11] H. Isozaki, K. Okajima, T. Ichinona, K. Fujii, E. Nomura, N. Izumi, Surgery for
gastric cancer in patients with cirrhosis, Surg. Today 27 (1997) 17e21.
[12] H.J. Jang, J.H. Kim, H.H. Song, K.H. Woo, M. Kim, S.H. Kae, et al., Clinical out-
comes of patients with liver cirrhosis who underwent curative surgery for
gastric cancer: a retrospective multi-center study, Dig. Dis. Sci. 53 (2008)
399e404.
[13] Japanese Gastric Cancer Association, Japanese gastric cancer treatment
guidelines 2010 (ver. 3), Gastric Cancer 14 (2011) 113e123.
[14] Japanese Gastric Cancer Association, Japanese classiﬁcation of gastric carci-
noma: 3rd English edition, Gastric Cancer 14 (2011) 101e112.
[15] W. Wu, Y. Huang, Application of praziquantel in schistosomiasis japonica
control strategies in China, Parasitol. Res. 112 (2013) 909e915.
[16] X.N. Zhou, J.G. Guo, X.H. Wu, Q.W. Jiang, J. Zheng, H. Dang, et al., Epidemiology
of schistosomiasis in the People's Republic of China, Emerg. Infect. Dis. 2007
(13) (2004) 1470e1476.
[17] G. Curro, G. Iapichino, G. Melita, C. Lorenzini, E. Cucinotta, Laparoscopic
cholecystectomy in Child-Pugh class C cirrhotic patients, JSLS 9 (2005)
311e315.
[18] I. Songun, H. Putter, E.M. Kranenbarg, M. Sasako, C.J. van de Velde, Surgical
treatment of gastric cancer: 15-year follow-up results of the randomised
nationwide Dutch D1D2 trial, Lancet Oncol. 11 (2010) 439e449.
